Reviewed,
UniProtKB/Swiss-Prot P35270 (SPRE_HUMAN)
Last modified
June 16, 2009.
Version 98.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Sepiapterin reductase Short name=SPR EC=1.1.1.153 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 261 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin. |
| Catalytic activity | 7,8-dihydrobiopterin + NADP+ = sepiapterin + NADPH. Tetrahydrobiopterin + 2 NADP+ = 6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH. |
| Subunit structure | Homodimer. |
| Subcellular location | |
| Post-translational modification | In vitro phosphorylation of Ser-213 by CaMK2 does not change kinetic parameters. |
| Involvement in disease | Depressed synthesis of tetrahydrobiopterin may play a role in a variety of human diseases. |
| Sequence similarities | Belongs to the sepiapterin reductase family. |
| biophysicochemical properties | Kinetic parameters: KM=14.3 µM for sepiapterin Ref.9 KM=10 µM for NADPH |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm |
| Ligand | NADP |
| Molecular function | Oxidoreductase |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | nitric oxide biosynthetic process Inferred from direct assay. Source: UniProtKB oxidation reduction Ref.1Traceable author statement. Source: UniProtKB tetrahydrobiopterin biosynthetic process Ref.1Traceable author statement. Source: UniProtKB |
| Cellular component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | NADP or NADPH binding Ref.1 Traceable author statement. Source: UniProtKB aldo-keto reductase activity Ref.1Traceable author statement. Source: UniProtKB sepiapterin reductase activity Ref.8Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 261 | 261 | Sepiapterin reductase | PRO_0000072149 | ||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 13 – 39 | 27 | NADP By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 28 – 32 | 5 | Pterin binding By similarity | |||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1 | 1 | N-acetylmethionine By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 213 | 1 | Phosphoserine; by CaMK2; in vitro Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 213 | 1 | S → A: Abolishes phosphorylation by CaMK2. No effect on kinetic parameters. Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 10 | 1 | C → R in BAD96662. Ref.4 | |||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 6 – 14 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 18 – 28 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 36 – 42 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 44 – 52 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 56 – 59 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 62 – 67 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 73 – 84 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 94 – 99 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 111 – 113 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 117 – 127 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 129 – 141 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 149 – 155 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 158 – 160 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 168 – 187 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 191 – 197 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 200 – 203 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 204 – 212 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 216 – 227 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 234 – 247 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 255 – 257 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and sequencing of cDNA encoding human sepiapterin reductase -- an enzyme involved in tetrahydrobiopterin biosynthesis." Ichinose H., Katoh S., Sueoka T., Titani K., Fujita K., Nagatsu T. Biochem. Biophys. Res. Commun. 179:183-189(1991) [PubMed: 1883349] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [2] | "Detection of a novel sepiapterin reductase mRNA: assay of mRNA in various cells and tissues of various species." Maier J., Schott K., Werner T., Bacher A., Ziegler I. Exp. Cell Res. 204:217-222(1993) [PubMed: 8440319] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Salivary gland. |
| [4] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [5] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed: 15815621] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Pancreas. |
| [8] | "Genomic organization and chromosomal localization of the human sepiapterin reductase gene." Ohye T., Hori T.A., Katoh S., Nagatsu T., Ichinose H. Biochem. Biophys. Res. Commun. 251:597-602(1998) [PubMed: 9792819] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [9] | "Mutational analysis of sites in sepiapterin reductase phosphorylated by Ca2+/calmodulin-dependent protein kinase II." Fujimoto K., Takahashi S.Y., Katoh S. Biochim. Biophys. Acta 1594:191-198(2002) [PubMed: 11825621] [Abstract] Cited for: KINETIC PARAMETERS, PHOSPHORYLATION AT SER-213, MUTAGENESIS OF SER-213. |
| [10] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M76231 mRNA. Translation: AAA60314.1. AK291856 mRNA. Translation: BAF84545.1. AK222942 mRNA. Translation: BAD96662.1. AC092630 Genomic DNA. Translation: AAY15035.1. CH471053 Genomic DNA. Translation: EAW99757.1. BC017310 mRNA. Translation: AAH17310.1. AB017547 Genomic DNA. Translation: BAA34534.1. | |||||||||||||
| IPI | IPI00017469. | ||||||||||||
| PIR | JQ1176. | ||||||||||||
| RefSeq | NP_003115.1. | ||||||||||||
| UniGene | Hs.301540 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P35270. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | P35270. | ||||||||||||
| PRIDE | P35270. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSG00000116096. Homo sapiens. [Contig view] | ||||||||||||
| GeneID | 6697. | ||||||||||||
| KEGG | hsa:6697. | ||||||||||||
| NMPDR | fig|9606.3.peg.18026. | ||||||||||||
Organism-specific databases | |||||||||||||
| GeneCards | GC02P073026. | ||||||||||||
| H-InvDB | HIX0002155. | ||||||||||||
| HGNC | HGNC:11257. SPR. | ||||||||||||
| MIM | 182125. gene+phenotype. | ||||||||||||
| Orphanet | 70594. Motor and cognitive disorder due to sepiapterin reductase deficiency. | ||||||||||||
| PharmGKB | PA36087. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | P35270. | ||||||||||||
| HOVERGEN | P35270. | ||||||||||||
| OMA | P35270. SVDPDMR. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BioCyc | MetaCyc:MON-13412. | ||||||||||||
| BRENDA | 1.1.1.153. 247. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P35270. | ||||||||||||
| Bgee | P35270. | ||||||||||||
| CleanEx | HS_SPR. | ||||||||||||
| GermOnline | ENSG00000116096. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR002198. DH_sc/Rdtase_SDR. IPR002347. Glc/ribitol_DH. IPR016040. NAD(P)-bd_dom. IPR006393. Sepiapterin_red. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:3.40.50.720. NAD(P)-bd. 1 hit. | ||||||||||||
| PANTHER | PTHR19410. ADH_short_C2. 1 hit. | ||||||||||||
| Pfam | PF00106. adh_short. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00081. GDHRDH. | ||||||||||||
| TIGRFAMs | TIGR01500. sepiapter_red. 1 hit. | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 26111. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | SPRE_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P35270 Secondary accession number(s): A8K741, Q53GI9, Q9UBB1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


